What is the appropriate dose of Meftal P syrup (mefenamic acid) for a child weighing 26.8 kg who is at least 6 months old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 11, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Meftal P Syrup Dosage for a 26.8 kg Child

For a child weighing 26.8 kg who is at least 6 months old, administer Meftal P syrup (mefenamic acid) at a dose of 6-7 mg/kg per dose, which equals approximately 160-188 mg per dose, given every 8 hours as needed for fever or pain.

Weight-Based Dosing Calculation

  • The standard pediatric dose of mefenamic acid is 4-6 mg/kg per dose for antipyretic and analgesic effects 1, 2
  • For a 26.8 kg child, this translates to 107-161 mg per dose using the 4-6 mg/kg range 1
  • However, studies demonstrate optimal antipyretic efficacy at 6 mg/kg per dose, which equals 161 mg per dose for this child 1
  • The maximum single dose should not exceed 500 mg 3

Practical Administration with Meftal P Syrup

  • Meftal P syrup typically contains 50 mg/5 mL concentration of mefenamic acid
  • For a 161 mg dose (6 mg/kg), administer approximately 16 mL of syrup 1
  • Alternatively, using a conservative 4 mg/kg approach yields 107 mg, requiring approximately 10.7 mL of syrup 2
  • The dose can be repeated every 8 hours as needed, not exceeding 3 doses in 24 hours 3

Clinical Efficacy Considerations

  • Mefenamic acid at 6 mg/kg demonstrates 2.5 times greater antipyretic effect compared to standard-dose paracetamol (15 mg/kg) 4
  • Time to fever reduction averages 84.90±30.42 minutes with mefenamic acid 6 mg/kg 1
  • Duration of antipyretic action extends to 8.82±3.83 hours before next fever spike 1
  • The medication provides effective analgesia for pain conditions including vaccination-related needle pain 2

Safety Profile and Monitoring

  • Mefenamic acid is safe for children ≥6 months of age at the recommended dosing 2
  • Adverse effects are negligible at therapeutic doses, with excellent safety profile in pediatric populations 1
  • The drug has a reported half-life of 2 hours, supporting the every 8-hour dosing interval 5
  • Monitor for gastrointestinal symptoms, though these are rare at recommended pediatric doses 1

Critical Prescribing Caveats

  • Do not use in children under 6 months of age due to insufficient safety data 2
  • Reserve mefenamic acid for fever unresponsive to paracetamol or when anti-inflammatory effects are specifically needed 1
  • Avoid concurrent use with other NSAIDs to prevent additive toxicity 1
  • Ensure adequate hydration, as NSAIDs can affect renal function in dehydrated states 1
  • Consider paracetamol as first-line antipyretic, using mefenamic acid when paracetamol proves inadequate 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.